GeneLink, Inc. (GNLKQ)
OTCMKTS · Delayed Price · Currency is USD
0.00004
-0.00006 (-60.00%)
At close: Apr 24, 2025
GeneLink Market Cap
GeneLink has a market cap or net worth of $10.6 thousand as of November 10, 2026. It is the 51,859th most valuable company in the world and the 7,795th biggest in the United States. Its market cap has increased by 3,900.38% in one year.
Market Cap
10.60K
Enterprise Value
n/a
Revenue
1.58M
Global Rank
Country Rank
#7,795 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 17, 1999, GeneLink's market cap has decreased from 4.78M to 10.60K, a decrease of -99.78%. That is a compound annual growth rate of -20.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 10.60K | 3,900.38% |
| Dec 1, 2023 | 265.00 | - |
| Dec 22, 2022 | 265.00 | - |
| Dec 31, 2021 | 265.00 | -99.86% |
| Dec 31, 2020 | 185.51K | 40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Bio-Path Holdings | 16.17K |
| Statera Biopharma | 14.52K |
| Scorpius Holdings | 12.23K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| Trevena | 10.64K |
| Carisma Therapeutics | 8.37K |